The service looks after around 4,000 patients. Stretched staff resources had led to long waiting times for outpatients and adverse outcomes, for example in emergency admissions.
The PHR has been championed by ESH’s IBD service lead Dr Azhar Ansari. The service has achieved clear benefits, with no reduction of clinical safety, to:
lower costs significantly
use limited staff resources better
improve patient experience
The PHR system now allows the IBD service to provide care to more patients that need close monitoring.
Patients use the PHR to record their symptoms and communicate with the IBD team, more often and remotely.
Remote monitoring benefits
The PHR enabled the ESH IBD service to introduce a new drug treatment, which costs less but needs more patient monitoring.
The PHR system allows patients to manage their use of the new treatment remotely.
The new treatment costs just £200 per patient per year and remote monitoring reduces side effects.
This in turn:
reduces the need for clinical intervention and escalation to more expensive therapies, which cost on average £12,500 per patient per year
leads to a 90% reduction in admissions and 80% reduction in operations
reduces the wait to access specialist care at the time of a flare-up, from 6 weeks to 1 week
saves patients travel time and costs, as they don’t need time off work to attend appointments
helps patients to feel in control
The new treatment, supported by PHR use, leads to potential savings of around £1.5 million a year on operations alone.
Last edited: 10 May 2021 9:12 am